Suchergebnisse - "Fangshi Xu"

PubPharm (6)

1

Pyroptosis-Related Risk Signature Exhibits Distinct Prognostic, Immune, and Therapeutic Landscapes in Hepatocellular Carcinoma

in: Frontiers in Genetics | 2022

von Yidi Zhao | Qingya Song | Fangshi Xu | +3

2

SLC1A5 Prefers to Play as an Accomplice Rather Than an Opponent in Pancreatic Adenocarcinoma

in: Frontiers in Cell and Developmental Biology | 2022

von Fangshi Xu | Hai Wang | Honghong Pei | +5

3

Pyroptosis regulators exert crucial functions in prognosis, progression and immune microenvironment of pancreatic adenocarcinoma: a bioinformatic and in vitro research

in: Bioengineered | 2022

von Zhenghai Bai | Fangshi Xu | Xiaodan Feng | +4

4

Tumor mutational burden presents limiting effects on predicting the efficacy of immune checkpoint inhibitors and prognostic assessment in adrenocortical carcinoma

in: BMC Endocrine Disorders | 2022

von Fangshi Xu | Yibing Guan | Peng Zhang | +5

5

The roles of ferroptosis regulatory gene SLC7A11 in renal cell carcinoma: A multi‐omics study

in: Cancer Medicine | 2021

von Fangshi Xu | Yibing Guan | Li Xue | +4

6

Identification of key genes and functions of circulating tumor cells in multiple cancers through bioinformatic analysis

in: BMC Medical Genomics | 2020

von Yibing Guan | Fangshi Xu | Yiyuan Wang | +4

1
[1]